(Completed) Tender for the Grinder Project in Workshop 303 of Guolong Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group
Category:
Time: 2024-10-22
【SUMMARY】
Tender for the Grinder Project in Workshop 303 of Guolong Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group
1. Tender Project:
Shijiazhuang Fourth Pharmaceutical Group Crushing Machine Project for Workshop 303 of Hebei Guolong Pharmaceutical Co., Ltd.
2. Tendering Entity:
Hebei Guolong Pharmaceutical Co., Ltd.
3. Construction Location:
Hebei Guolong Pharmaceutical, No. 9 Xingye Street, Liangcun Economic and Technological Development Zone, Shijiazhuang
4. Tendering Time:
To be determined; you will be notified by phone once confirmed.
5. Tendering Method:
On-site bidding.
5.1 This batch of equipment is procured through a URS-based tender process, in which bidders shall comprehensively evaluate their quotations and project schedules in light of the URS provided by Party A.
5.2. The unit prices for this batch of equipment shall not be adjusted after the contract is signed.
6. Validity Period of the Bid Document:
Should be no less than 90 days.
7. Address for Submission of Bidding Documents and Contact Person:
Address: No. 9 Xingye Street, Liangcun Economic and Technological Development Zone, Shijiazhuang, Hebei Guolong Pharmaceutical
Contact: Wu Bingchuan, 0311-83099655
8. Name:
Hebei Guolong Pharmaceutical Co., Ltd.
Taxpayer Identification Number: 911301005689263244
Address and Telephone: No. 9 Xingye Street, Shijiazhuang Economic and Technological Development Zone, Hebei Province, 0311-67167240
Account-opening bank and account number: Agricultural Bank of China, Gaocheng Liangcun Development Zone Sub-branch, Account No. 50-314901040021214
9. Return of Bid Bond:
The bid bond (principal amount) of the successful bidder shall be converted into a performance bond upon the execution and entry into force of the contract; the bid bonds (principal amounts) of unsuccessful bidders shall be refunded without interest after the tenderer has determined the successful bidder.
The bid bond is one of the constituent parts of the bidding documents; failure to submit the bid bond as required shall be deemed a non-response to the tender documents. In any of the following circumstances, the bid bond shall not be refunded:
A. The bidder withdraws its tender document within the prescribed tender validity period.
B. The successful bidder fails to enter into a contract with the tendering entity.
C. Bidder’s breach of contract.
D. Abandoning the bid after winning the contract.
10. Installation and Delivery Period:
The delivery period shall commence upon receipt of the Notice of Award.
11. Principal Contract Terms:
Payment terms: 30% prepayment, 30% prior to shipment, 30% upon acceptance, and 10% retention for warranty. Bank electronic acceptances are accepted.
12. Clarification, amendment, or supplement to the tender documents:
Bidders shall carefully review the tender documents and, if they have any questions, shall submit a request for clarification to the tenderer prior to the prescribed bid submission deadline; any clarifications, amendments, or supplements shall form an integral part of the tender documents.
13. Bid opening time, location, and requirements:
Bid opening time: To be announced separately
Bid Opening Location: Xingye Street, Shijiazhuang Economic and Technological Development Zone
Attendees: Bidders shall dispatch technical personnel to attend the tendering meeting.
14. Additional Note:
Bidders shall arrive at the bidding venue on time; otherwise, they shall be deemed to have voluntarily withdrawn their bids.
Bidders shall not, in any form, offer bribes to any relevant personnel of the tendering entity; upon verification, their bidding qualification shall be revoked.
During the bidding process, please communicate promptly if any questions arise.
Keywords:
More Announcements
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091